EP100: Decoding DNA and engineering biology: perspectives on the future of genomics with Dr. Matthew Hurles, Director of the Wellcome Sanger Institute.

June 8th, 2023  |  43 mins 32 secs

In this milestone episode, we welcome Dr Matthew Hurles, a geneticist and pioneer in the field of human genomics.

EP99: Exploring the frontiers of cancer research with Dr. Harold E Varmus

May 25th, 2023  |  45 mins 12 secs

EP 98: Cancer, ageing, and somatic mutation variation across mammals with Alex Cagan (Wellcome Sanger Institute)

May 11th, 2023  |  38 mins 37 secs

EP 97: Proteomics deep dive with Cindy Lawley (Olink)

April 26th, 2023  |  1 hr 17 secs

In this episode, Patrick is joined by Cindy Lawley, Senior Director of Population Health at Olink Proteomics and co-host of the Proteomics in Proximity podcast. Cindy has worked with major population genomics programs, including the UK Biobank, to bring together proteomics, genomics, and deep phenotyping using the Olink platform.

EP 96: CEO of Montai Health, Margo Georgiadis, talks the intersection of nature and AI

April 13th, 2023  |  51 mins 5 secs

This week, we’re welcoming the CEO of Montai Health, Margo Georgiadis, to the podcast to discuss their AI platform that uses literature and wet lab experiments to analyse “the most privileged chemistry on Earth” to find new treatments for chronic diseases.

EP 95: Resharing Eric Topol on how Machine Learning & AI can Contribute to the Future of Healthcare

March 31st, 2023  |  38 mins 56 secs

In 2019, we had the pleasure of speaking with Dr Eric Topol, author of ‘The Patient Will See You Now’ and ‘Deep Medicine.’ Now, we're re-sharing the interview when the conversation is more relevant than ever.

EP 94: Alnylam’s Dr Paul Nioi on how genetics is used in drug target discovery

March 16th, 2023  |  44 mins 52 secs

alynlam, our future health, population genomics, sano genetics, target discovery, uk biobank

In this jam-packed 45-minute episode, we’re joined by Dr Paul Nioi, Vice President of Discovery and Translational Research at Alnylam Pharmaceuticals and Chair of the Founders Board for Our Future Health.

EP 93: International Perspectives on Access to Genetic Testing in ALS

January 24th, 2023  |  41 mins 20 secs

als, dr patrick short, genetics, international als, precision medicine, sano genetics

In this webinar, Paul Wicks leads the discussion with Professor Ammar Al-Chalabi, Dr Patrick Short and Kristina Salmon on international perspectives on genetic testing for ALS.

EP 92: Four Predictions for 2023

January 5th, 2023  |  13 mins 41 secs

genetics, genetics 2023, genetics predictions

From changing drug pricing legislation to AI breakthroughs, in the first episode of The Genetics Podcast for 2023, Patrick makes four predictions for the biggest stories of 2023.

EP 91: 2022 Genetics Round-up with Dr Veera Rajagopal

December 24th, 2022  |  1 hr 29 mins

dna 2022, genetics, genetics news, precision medicine, sano

In the final episode of The Genetics Podcast for 2022, we’re joined by Dr Veera Rajagopal, who is known as the ‘GWAS storyteller’ on Twitter for his prolific threads breaking down the latest findings in genetics.

EP 90: Patient-centric drug development in ALS with Ronald van der Geest, Chief Development Officer of Treeway

December 8th, 2022  |  35 mins 17 secs

als, ronald va der geest, treeway

This week Patrick is joined by Treeway Chief Development Officer Ronald van der Geest. Join them as they discuss Treeway's roots, the four major disciplines required for successful development of novel treatments, and the landscape of ALS.

EP 89: Baroness Nicola Blackwood on the UK's leading role in delivering 'genomic healthcare for everyone'

November 24th, 2022  |  33 mins 22 secs

baroness blackwood, genetic testing, genetics, genomics england, nicola blackwood

This week Patrick is joined by Baroness Nicola Blackwood of North Oxford. Nicola is chair of Genomics England, a diverse community of genomic clinicians and researchers providing a world-class service platform for genetic testing to patients.

EP 88: Precision oncology: how Next Generation Sequencing (NGS) is powering care today and the treatments of the future with Christine Ward (Takeda) and Geoff Oxnard (Foundation Medicine)

November 10th, 2022  |  42 mins 30 secs

clinicalgenetics, genetics, precisionmedicine, thegeneticspodcast

In this episode, guests Christine Ward, VP and Head of Oncology and Cell Therapy Precision & Translational Medicine at Takeda and Geoff Oxnard, Thoracic Oncologist and VP of Foundation Medicine talk to Patrick about Next Generation Sequencing (NGS) in precision oncology.

EP 87: Representation Matters: Why equitable access and community engagement are critical in genetic research

October 27th, 2022  |  49 mins 46 secs

diversity, precisionmedicine, representation, sanogenetics

In the age of precision medicine, ensuring equitable access and representation from participants of all communities is of vital importance when conducting genetic research.

EP 86: Heidi Rehm PhD, Chief Genomics Officer at Massachusetts General Hospital on curating and collaborating genomic datasets to guide the future of diagnostic and clinical research

October 13th, 2022  |  36 mins 59 secs

clinicalgenetics, genetics, precisionmedicine, thegeneticspodcast

Patrick speaks to Heidi Rehm who is at the top of the field of genome interpretation and medical genetics.

EP 85: Dr Jessica Kissinger on large-scale parasite genomics and the power of multi-omic data

September 29th, 2022  |  33 mins 55 secs

biology, genetics, pathogens, thegeneticspodcast

In this episode, we explore major findings in the field and Dr Kissinger's vision of large-scale interoperable datasets driving novel discoveries. Plus, Dr Kissinger shares her recent and personal experience of diagnosis with a rare disease, Ehlers-Danlos Syndrome, that puts everything into perspective.